NCT06619093View on ClinicalTrials.gov

Relationship Between Biological Phenotype, Clinical Severity of Sickle Cell Disease, and Blood Coagulation

Not yet recruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

February 1, 2028

Study Completion Date

February 1, 2028

Conditions

Sickle Cell Disease (SCD)

Interventions

OTHER

blood sampling

3 additional citrate tubes (2.7mL)

Trial Locations (2)

69008

Insitut Hématologique et Oncologique Pédiatrique (IHOPe), Lyon

Service de Médecine Interne - Hôpital Edouard Herriot, Lyon

All Listed Sponsors

collaborator

Laboratoire Interuniversitaire de Biologie de la Motricité (UCBL1) UR7424

UNKNOWN

lead

Hospices Civils de Lyon

OTHER

NCT06619093 - Relationship Between Biological Phenotype, Clinical Severity of Sickle Cell Disease, and Blood Coagulation | Biotech Hunter | Biotech Hunter